Cutler Group LP Rhythm Pharmaceuticals, Inc. Put Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2023 Jan 18, 2024	BUY	$21.39 - $49.64 $2,139 - $4,964	100 New	100 $0
Q3 2022 Oct 25, 2022	BUY	$4.3 - $30.85 $3,870 - $27,765	900 New	900 $1,000
Q3 2021 Oct 26, 2021	SELL	$11.68 - $20.72 $98,112 - $174,048	-8,400 Closed	0 $0
Q2 2021 Jul 19, 2021	SELL	$18.52 - $22.55 $5,556 - $6,765	-300 Reduced 3.45%	8,400 $79,000
Q1 2021 Apr 26, 2021	BUY	$20.25 - $39.49 $147,825 - $288,277	7,300 Added 521.43%	8,700 $82,000
Q4 2020 Jan 21, 2021	SELL	$21.17 - $32.61 $8,468 - $13,044	-400 Reduced 22.22%	1,400 $7,000
Q3 2020 Oct 27, 2020	BUY	$18.13 - $30.61 $32,634 - $55,098	1,800 New	1,800 $9,000

192

67.3M

834K

78.6K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $3.13B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.